Cetoacidosis por empagliflozina post histerectomía

Claudia González León; Jorge Macia Ubierna; Hugo Mendieta Zerón

doi:10.31403/rpgo.v66i2235

Authors

Claudia González León Hospital Materno-Perinatal “Mónica Pretelini Sáenz” (HMPMPS), Instituto de Salud del Estado de México (ISEM), México
Jorge Macia Ubierna Hospital Materno-Perinatal “Mónica Pretelini Sáenz” (HMPMPS), Instituto de Salud del Estado de México (ISEM), México
Hugo Mendieta Zerón Hospital Materno-Perinatal “Mónica Pretelini Sáenz” (HMPMPS), Instituto de Salud del Estado de México (ISEM), México; Facultad de Medicina, Universidad Autónoma del Estado de México (UAEMex), México

DOI:

https://doi.org/10.31403/rpgo.v66i2235

Abstract

A 42-year-old female patient received a diagnosis of type 2 diabetes mellitus 3 years ago, and was treated with empagliflozin/metformin. She had a surgical intervention for uterine myomatosis, and presented immediately after the surgery neurological deterioration, metabolic acidosis without hyperglycemia, and hydroelectrolytic imbalance. She was admitted to the intensive care unit and required treatment with hemodialysis and peritoneal dialysis due to refractory acidosis. She was discharged in good condition after 17 days of hospitalization.